In utero conversion of supraventricular tachycardia with digoxin and procainamide at 17 weeks' gestation.
The earliest reported case of fetal supraventricular tachycardia at 17 weeks' gestation causing hydrops fetalis is presented. Maternal treatment with digoxin and procainamide successfully cardioverted the fetus with resolution of the hydrops. Using this combination, sinus rhythm was maintained until term.
Battiste
C E
CE
Department of Obstetrics and Gynecology, University of Kansas School of Medicine-Wichita.
Neff
T W
TW
Evans
J F
JF
Cline
B W
BW
D004077:Digoxin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005315:Fetal Diseases / Q000188:drug therapy*; D005865:Gestational Age; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology; D007231:Infant, Newborn; D008297:Male; D011342:Procainamide / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D013617:Tachycardia, Supraventricular / Q000150:complications / Q000188:drug therapy*
D004077:Digoxin; D011433:Propranolol; D011342:Procainamide